Chonluten
Investigación moderadaEDG Tripeptide | Bronchial/Lung Bioregulator
Chonluten is a Khavinson bioregulator tripeptide (EDG) derived from respiratory lung tissue. Developed at Russia's St.
Datos moleculares y de investigación
- Secuencia
- Glu-Asp-Gly
- Peso molecular
- 319 Da
- Vida media
- Minutes (short peptide); effects persist via epigenetic changes
- Rutas (investigación)
- oral, sublingual, injectable
- Almacenamiento
- Capsules: room temperature; Injectable lyophilized: 2-8°C; Reconstituted: 2-8°C refrigerated
Overview
Chonluten is a Khavinson bioregulator tripeptide (EDG) derived from respiratory lung tissue. Developed at Russia’s St. Petersburg Institute of Bioregulation and Gerontology, it targets the bronchopulmonary system with secondary activity in the GI tract. Research shows it regulates genes related to inflammation, antioxidant activity, and proliferation responses. Chonluten inhibits TNF production in monocytes and has been studied as a potential geroprotective agent that may support lung function in conditions like COPD.
Mechanism of action
Chonluten works through epigenetic regulation, penetrating cell and nuclear membranes to bind promoter or suppressor regions of DNA and modulate transcriptional control. It regulates genes including c-Fos, HSP70 (heat-shock protein), SOD (superoxide dismutase), COX-2, and TNF-alpha related to oxidative stress and proliferative regulation. The peptide inhibits TNF production in monocytes exposed to pro-inflammatory LPS, promoting attenuation of inflammatory action through TNF tolerance mechanisms.
Key research findings
- Normalizes respiratory system function
- Regulates protein synthesis in lung tissue
- Inhibits inflammatory TNF production
- Restores lung alveolar tissues
- Maintains bronchial mucous membranes
- Supports antioxidant gene expression
- May slow cell aging (geroprotective)
- Modulates mucosal function
Research applications
Respiratory Support
- Bronchial Function — Normalizes respiratory system function through gene expression regulation.
- Lung Tissue Health — Restores and maintains lung alveolar tissues and bronchial mucous membranes.
- COPD Support — May modulate mucosal function in chronic obstructive pulmonary disease.
Anti-Inflammatory
- TNF Modulation — Inhibits TNF production in monocytes, reducing inflammatory responses.
- Oxidative Stress — Supports SOD and antioxidant gene expression.
Anti-Aging
- Geroprotection — Researched as potential agent that may slow cell aging.
- Gene Expression Regulation — Modulates c-Fos and proliferative gene activity.
Preguntas frecuentes sobre Chonluten
Can Chonluten be taken orally or must it be injected?+
Chonluten is available in multiple forms including oral capsules, sublingual, and injectable routes. As a short tripeptide, it has favorable absorption when taken orally (10-20mg daily) or sublingually for enhanced absorption. Most commonly used as a 10-20 day oral cycle, though injectable forms bypass GI metabolism for direct delivery.
How often should Chonluten cycles be repeated?+
Standard protocol involves 10-20 day cycles repeated 2-3 times per year with breaks in between. After completing a cycle, effects persist for weeks due to epigenetic changes in gene expression, so spacing cycles allows the body to maintain benefits while avoiding habituation.
Does Chonluten help with chronic respiratory issues like COPD?+
Research shows Chonluten has moderate effectiveness for COPD support through TNF inhibition and restoration of lung alveolar tissues. It normalizes respiratory function through gene expression regulation, though it works best as a preventative and maintenance therapy rather than an acute treatment for active respiratory emergencies.
What makes Chonluten different from other immune-supporting peptides?+
Chonluten is specifically derived from bronchial lung tissue and targets the respiratory system primarily, unlike broad immune peptides. It regulates genes like c-Fos, HSP70, SOD, and TNF-alpha to reduce inflammatory responses and support lung tissue health, making it unique for respiratory-specific immune modulation.
References
Péptidos relacionados
Crystagen
Moderate researchEDP Tripeptide | Thymus Immune Bioregulator
Crystagen is a Khavinson bioregulator tripeptide (EDP) identified in thymalin with selective action on thymus tissues. Developed at Russia's St.
Glutathione
Extensively studiedL-Glutathione | Master Antioxidant Tripeptide
Glutathione is the body's master antioxidant, a tripeptide produced naturally by the liver.
Livagen
Moderate researchKEDA Tetrapeptide | Liver Bioregulator
Livagen is a Khavinson bioregulator tetrapeptide (KEDA) with significant hepatoprotective and immunomodulatory properties.
NA-Selank Amidate
Moderate researchN-Acetyl Selank Amidate | Enhanced Anxiolytic Nootropic
NA-Selank Amidate is an enhanced version of Selank, the anxiolytic nootropic peptide developed at Russia's Institute of Molecular Genetics.